eGFR

Is it ready for early identification of CKD?

Michal L. Melamed, Carolyn Ann Bauer, Thomas H. Hostetter

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Reporting estimated glomerular filtration rate (eGFR) with serum creatinine simply provides the information for which the serum creatinine was ordered in the first place. Mass or universal screening is not the purpose of eGFR reporting. Furthermore, such mass screening does not seem justified. Rather, testing of high-risk groups with eGFR and urinary albumin is useful. Population estimates of the prevalence of chronic kidney disease in the United States that use the Kidney Disease Outcomes Quality Initiative staging system lead to disturbingly high estimates. Many of these people are elderly with marginally depressed GFRs and for whom there are no known therapeutic implications. However, an even more disturbing fraction of people with serious and progressive renal disease are not diagnosed, counseled, or treated. Reporting of eGFR is only one tool in attempting to rectify this latter problem. Nephrologists need to educate patients and their primary care colleagues in the use of this tool.

Original languageEnglish (US)
Pages (from-to)1569-1572
Number of pages4
JournalClinical Journal of the American Society of Nephrology
Volume3
Issue number5
DOIs
StatePublished - Sep 2008

Fingerprint

Glomerular Filtration Rate
Creatinine
Mass Screening
Kidney Diseases
Serum
Chronic Renal Insufficiency
Albumins
Primary Health Care
Kidney
Population
Therapeutics

ASJC Scopus subject areas

  • Nephrology
  • Transplantation
  • Epidemiology
  • Critical Care and Intensive Care Medicine

Cite this

eGFR : Is it ready for early identification of CKD? / Melamed, Michal L.; Bauer, Carolyn Ann; Hostetter, Thomas H.

In: Clinical Journal of the American Society of Nephrology, Vol. 3, No. 5, 09.2008, p. 1569-1572.

Research output: Contribution to journalArticle

@article{d8658c6c154b457ca071c2451c03b44d,
title = "eGFR: Is it ready for early identification of CKD?",
abstract = "Reporting estimated glomerular filtration rate (eGFR) with serum creatinine simply provides the information for which the serum creatinine was ordered in the first place. Mass or universal screening is not the purpose of eGFR reporting. Furthermore, such mass screening does not seem justified. Rather, testing of high-risk groups with eGFR and urinary albumin is useful. Population estimates of the prevalence of chronic kidney disease in the United States that use the Kidney Disease Outcomes Quality Initiative staging system lead to disturbingly high estimates. Many of these people are elderly with marginally depressed GFRs and for whom there are no known therapeutic implications. However, an even more disturbing fraction of people with serious and progressive renal disease are not diagnosed, counseled, or treated. Reporting of eGFR is only one tool in attempting to rectify this latter problem. Nephrologists need to educate patients and their primary care colleagues in the use of this tool.",
author = "Melamed, {Michal L.} and Bauer, {Carolyn Ann} and Hostetter, {Thomas H.}",
year = "2008",
month = "9",
doi = "10.2215/CJN.02370508",
language = "English (US)",
volume = "3",
pages = "1569--1572",
journal = "Clinical Journal of the American Society of Nephrology",
issn = "1555-9041",
publisher = "American Society of Nephrology",
number = "5",

}

TY - JOUR

T1 - eGFR

T2 - Is it ready for early identification of CKD?

AU - Melamed, Michal L.

AU - Bauer, Carolyn Ann

AU - Hostetter, Thomas H.

PY - 2008/9

Y1 - 2008/9

N2 - Reporting estimated glomerular filtration rate (eGFR) with serum creatinine simply provides the information for which the serum creatinine was ordered in the first place. Mass or universal screening is not the purpose of eGFR reporting. Furthermore, such mass screening does not seem justified. Rather, testing of high-risk groups with eGFR and urinary albumin is useful. Population estimates of the prevalence of chronic kidney disease in the United States that use the Kidney Disease Outcomes Quality Initiative staging system lead to disturbingly high estimates. Many of these people are elderly with marginally depressed GFRs and for whom there are no known therapeutic implications. However, an even more disturbing fraction of people with serious and progressive renal disease are not diagnosed, counseled, or treated. Reporting of eGFR is only one tool in attempting to rectify this latter problem. Nephrologists need to educate patients and their primary care colleagues in the use of this tool.

AB - Reporting estimated glomerular filtration rate (eGFR) with serum creatinine simply provides the information for which the serum creatinine was ordered in the first place. Mass or universal screening is not the purpose of eGFR reporting. Furthermore, such mass screening does not seem justified. Rather, testing of high-risk groups with eGFR and urinary albumin is useful. Population estimates of the prevalence of chronic kidney disease in the United States that use the Kidney Disease Outcomes Quality Initiative staging system lead to disturbingly high estimates. Many of these people are elderly with marginally depressed GFRs and for whom there are no known therapeutic implications. However, an even more disturbing fraction of people with serious and progressive renal disease are not diagnosed, counseled, or treated. Reporting of eGFR is only one tool in attempting to rectify this latter problem. Nephrologists need to educate patients and their primary care colleagues in the use of this tool.

UR - http://www.scopus.com/inward/record.url?scp=53749088208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=53749088208&partnerID=8YFLogxK

U2 - 10.2215/CJN.02370508

DO - 10.2215/CJN.02370508

M3 - Article

VL - 3

SP - 1569

EP - 1572

JO - Clinical Journal of the American Society of Nephrology

JF - Clinical Journal of the American Society of Nephrology

SN - 1555-9041

IS - 5

ER -